BiomX
PHGE
17 hedge funds and large institutions have $7.32M invested in BiomX in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
13% more funds holding
Funds holding: 15 → 17 (+2)
0.25% more ownership
Funds ownership: 2.66% → 2.91% (+0.25%)
21% less capital invested
Capital invested by funds: $9.24M → $7.32M (-$1.92M)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$649K |
| 2 |
JP Morgan Chase
New York
|
+$322K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$24.1K |
| 4 |
CS
Clear Street
New York
|
+$1.02K |
| 5 |
CWA
Carolina Wealth Advisors
Myrtle Beach,
South Carolina
|
+$114 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$441K |
| 2 |
HCM
Heights Capital Management
San Francisco,
California
|
-$248K |
| 3 |
8GI
8VC GP I
Austin,
Texas
|
-$111K |
| 4 |
JJ
Johnson & Johnson
New Brunswick,
New Jersey
|
-$71.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.86K |
PHGE Hedge Fund Activity: Q4 2024 in Review
17 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q4 2024, worth a combined $7.32M — down 21% from $9.24M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PHGE positions and 4 closed out — a net gain of 2 holders — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $649K. The largest seller was ADAR1 Capital Management, exiting entirely with an estimated $441K sold.
- 17 institutional investors held BiomX (PHGE) as of Q4 2024, up from 15 in Q3 2024.
- Funds reported $7.32M of BiomX stock for Q4 2024, down 21% quarter-over-quarter.
- 6 funds opened new BiomX positions in Q4 2024 and 4 closed out, a net change of +2 holders.
- The largest BiomX buyer in Q4 2024 was Alyeska Investment Group, an estimated $649K added.
- The largest BiomX seller in Q4 2024 was ADAR1 Capital Management, an estimated $441K sold.
Based on aggregated 13F filings for Q4 2024.